Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma
Clinical trial NCT03528642 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03528642
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2026-09-11
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.